News Report | February 16, 2020
Single-Dose Psilocybin Alleviated Anxiety & Depression In Individuals With Cancer
Psychotherapy combined with a one-time, single-dose treatment of psilocybin was associated with improvements in emotional and existential distress, quality of life, and spiritual well-being in people being treated for cancer. These improvements met criteria for clinically significant antidepressant response for 60% to 80% of the participants up to 4.5 years after the dose was administered. Psilocybin is a compound found in psychedelic mushrooms.
Researchers reported that 100% of participants attributed positive life changes to the psilocybin-assisted therapy. They concluded that psilocybin-assisted psychotherapy is promising for long-term relief from cancer-related psychiatric distress.
These . . .